UNITED THERAPEUTICS (UTH BE) stock market data APIs
€458.4469
4.99(1.1%)
as of March 18, 2026
Try our APIs with
free plan!
UNITED THERAPEUTICS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for UTH.BE.
Prev. Close
458.4469
Open
463.4396
High
463.4577
Low
457.9953
52 wk Range
237.2-476.2
Market Cap
7 520 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get UNITED THERAPEUTICS data using free add-ons & libraries
Get UNITED THERAPEUTICS Fundamental Data
UNITED THERAPEUTICS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
UNITED THERAPEUTICS News
New
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
The phase 3 ADVANCE OUTCOMES study of ralinepag met its primary endpoint and several important secondary endpoints, including increasing odds of clinical improvement by 47%, in predominantly pre-treat...
UTHR Tops Q4 Earnings Estimates, Shares Surge 13% on Strong Guidance
United Therapeutics UTHR reported fourth-quarter 2025 earnings per share (EPS) of $7.70, which surpassed the Zacks Consensus Estimate of $6.78. Earnings increased 24% year over year, driven by higher ...
United Therapeutics Corp (UTHR) Q4 2025 Earnings Call Highlights: Record Revenue and Promising ...
This article first appeared on GuruFocus. Total Revenue: $790 million for Q4 2025, representing 7% growth from Q4 2024. Annual Revenue: Surpassed $3 billion for the first time, with 11% growth over 2...
Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key Metrics
For the quarter ended December 2025, United Therapeutics (UTHR) reported revenue of $790.2 million, up 7.4% over the same period last year. EPS came in at $7.70, compared to $6.19 in the year-ago quar...
Get UNITED THERAPEUTICS fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
